NUVA logo

NuVasive (NUVA) EBIT

Annual EBIT

$69.75 M
+$107.07 M+286.84%

31 December 2022

3-Year Change

+204.28%
NUVA annual earnings before interest & taxes is up +204.28% over the past 3 years

All-time High

$254.63 M
NUVA annual earnings before interest & taxes is currently -72.61% below its historical high of $254.63 million

Annual EBIT Formula

Revenue − COGS − Operating Expenses
Annual Revenue$1.20 B
NUVA annual revenue is $1.20 billion
Annual Gross Profit$865.43 M
NUVA annual gross profit is $865.43 million
Annual Net Income$40.41 M
NUVA annual net profit is $40.41 million

NUVA EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

$18.49 M
+$13.94 M+305.75%

30 June 2023

3-Year Change

+193.92%
NUVA quarterly earnings before interest & taxes is up +193.92% over the past 3 years

All-time High

$60.22 M
NUVA quarterly earnings before interest & taxes is currently -69.29% below its historical high of $60.22 million
Quarterly Gross Profit$228.31 M
NUVA quarterly gross profit is $228.31 million
Quarterly Operating Expenses$200.53 M
NUVA quarterly total operating expenses is $200.53 million
Quarterly Revenue$317.79 M
NUVA quarterly revenue is $317.79 million
Quarterly Net Income$7.36 M
NUVA quarterly net profit is $7.36 million

NUVA Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

$60.92 M
+$14.84 M+32.21%

30 June 2023

3-Year Change

+317.34%
NUVA TTM earnings before interest & taxes is up +317.34% over the past 3 years

All-time High

$141.10 M
NUVA TTM earnings before interest & taxes is currently -56.82% below its historical high of $141.10 million
TTM Revenue$1.23 B
NUVA TTM revenue is $1.23 billion
TTM Gross Profit$878.73 M
NUVA TTM gross profit is $878.73 million
Annual Operating Expenses$782.00 M
NUVA annual total operating expenses is $782.00 million
TTM Net Income$28.45 M
NUVA TTM net profit is $28.45 million

NUVA TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUVA EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+204.3%+193.9%+317.3%
5 y5 years+49.7%-27.3%-40.2%

NUVA EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-72.6%-69.3%-56.8%

NuVasive EBIT History

DateAnnualQuarterlyTTM
June 2023
-
$18.49 M(+305.7%)
$60.92 M(+32.2%)
Mar 2023
-
$4.56 M(-87.5%)
$46.08 M(-33.9%)
Dec 2022
$69.75 M(-286.8%)
$36.34 M(+2265.6%)
$69.75 M(+1712.0%)
Sept 2022
-
$1.54 M(-57.9%)
$3.85 M(-122.1%)
June 2022
-
$3.65 M(-87.1%)
-$17.38 M(+92.9%)
Mar 2022
-
$28.22 M(-195.5%)
-$9.01 M(-75.9%)
Dec 2021
-$37.33 M(-262.9%)
-$29.56 M(+50.1%)
-$37.33 M(-355.7%)
Sept 2021
-
-$19.69 M(-263.8%)
$14.60 M(-76.4%)
June 2021
-
$12.02 M(<-9900.0%)
$61.86 M(+5147.2%)
Mar 2021
-
-$100.00 K(-100.4%)
$1.18 M(-94.9%)
Dec 2020
$22.92 M(-80.7%)
$22.37 M(-18.9%)
$22.92 M(-47.2%)
Sept 2020
-
$27.57 M(-156.7%)
$43.41 M(+5.2%)
June 2020
-
-$48.66 M(-324.8%)
$41.27 M(-65.7%)
Mar 2020
-
$21.64 M(-49.5%)
$120.47 M(+1.2%)
Dec 2019
$119.04 M(+155.6%)
$42.85 M(+68.5%)
$119.04 M(+16.8%)
Sept 2019
-
$25.44 M(-16.7%)
$101.92 M(+3.1%)
June 2019
-
$30.53 M(+51.0%)
$98.82 M(+4.5%)
Mar 2019
-
$20.22 M(-21.4%)
$94.59 M(+103.1%)
Dec 2018
$46.58 M(-57.8%)
$25.73 M(+15.2%)
$46.58 M(-5.3%)
Sept 2018
-
$22.34 M(-15.1%)
$49.18 M(-14.1%)
June 2018
-
$26.30 M(-194.6%)
$57.23 M(-3.9%)
Mar 2018
-
-$27.79 M(-198.1%)
$59.53 M(-46.1%)
Dec 2017
$110.38 M(+4.8%)
$28.33 M(-6.8%)
$110.38 M(-0.1%)
Sept 2017
-
$30.39 M(+6.3%)
$110.52 M(+8.8%)
June 2017
-
$28.59 M(+24.0%)
$101.58 M(-23.7%)
Mar 2017
-
$23.07 M(-19.0%)
$133.20 M(+26.5%)
Dec 2016
$105.30 M(-25.4%)
$28.47 M(+32.7%)
$105.30 M(-1.3%)
Sept 2016
-
$21.45 M(-64.4%)
$106.73 M(-6.5%)
June 2016
-
$60.22 M(-1346.0%)
$114.15 M(+42.9%)
Mar 2016
-
-$4.83 M(-116.2%)
$79.86 M(-43.4%)
Dec 2015
$141.10 M(+744.8%)
$29.90 M(+3.6%)
$141.10 M(+3.8%)
Sept 2015
-
$28.86 M(+11.3%)
$135.94 M(+12.2%)
June 2015
-
$25.93 M(-54.0%)
$121.15 M(+21.3%)
Mar 2015
-
$56.41 M(+127.9%)
$99.87 M(+498.0%)
Dec 2014
$16.70 M(-54.8%)
$24.75 M(+75.9%)
$16.70 M(+127.6%)
Sept 2014
-
$14.07 M(+202.4%)
$7.34 M(-9.7%)
June 2014
-
$4.65 M(-117.4%)
$8.12 M(+144.7%)
Mar 2014
-
-$26.76 M(-274.0%)
$3.32 M(-91.0%)
Dec 2013
$36.95 M(-5.2%)
$15.38 M(+3.6%)
$36.95 M(+37.5%)
Sept 2013
-
$14.85 M(-9871.1%)
$26.87 M(+7.0%)
June 2013
-
-$152.00 K(-102.2%)
$25.10 M(-33.8%)
Mar 2013
-
$6.86 M(+29.5%)
$37.94 M(-2.6%)
DateAnnualQuarterlyTTM
Dec 2012
$38.97 M(-147.4%)
$5.30 M(-59.5%)
$38.97 M(+62.6%)
Sept 2012
-
$13.09 M(+3.2%)
$23.96 M(-130.5%)
June 2012
-
$12.69 M(+60.8%)
-$78.56 M(-1.2%)
Mar 2012
-
$7.89 M(-181.3%)
-$79.53 M(-3.2%)
Dec 2011
-$82.13 M(-352.0%)
-$9.70 M(-89.2%)
-$82.13 M(+34.1%)
Sept 2011
-
-$89.43 M(-863.5%)
-$61.25 M(-261.5%)
June 2011
-
$11.71 M(+121.5%)
$37.92 M(+9.5%)
Mar 2011
-
$5.29 M(-52.7%)
$34.63 M(+6.3%)
Dec 2010
$32.59 M(+145.3%)
$11.18 M(+14.9%)
$32.59 M(+25.4%)
Sept 2010
-
$9.73 M(+15.4%)
$25.98 M(+14.3%)
June 2010
-
$8.43 M(+160.2%)
$22.72 M(+18.4%)
Mar 2010
-
$3.24 M(-29.2%)
$19.19 M(+44.4%)
Dec 2009
$13.29 M(-160.5%)
$4.58 M(-29.3%)
$13.29 M(-723.2%)
Sept 2009
-
$6.47 M(+32.2%)
-$2.13 M(-85.6%)
June 2009
-
$4.90 M(-283.9%)
-$14.84 M(-27.3%)
Mar 2009
-
-$2.66 M(-75.4%)
-$20.42 M(-7.0%)
Dec 2008
-$21.96 M(+27.3%)
-$10.84 M(+73.9%)
-$21.96 M(+63.1%)
Sept 2008
-
-$6.23 M(+818.0%)
-$13.46 M(+24.5%)
June 2008
-
-$679.00 K(-83.8%)
-$10.81 M(-28.8%)
Mar 2008
-
-$4.20 M(+79.4%)
-$15.18 M(-12.0%)
Dec 2007
-$17.25 M(-49.4%)
-$2.34 M(-34.6%)
-$17.25 M(-9.7%)
Sept 2007
-
-$3.58 M(-28.9%)
-$19.10 M(-27.7%)
June 2007
-
-$5.04 M(-19.7%)
-$26.42 M(-36.6%)
Mar 2007
-
-$6.28 M(+49.7%)
-$41.69 M(-6.6%)
Dec 2006
-$34.11 M(+83.4%)
-$4.20 M(-61.5%)
-$44.61 M(-0.5%)
Sept 2006
-
-$10.90 M(-46.3%)
-$44.82 M(+12.7%)
June 2006
-
-$20.31 M(+120.6%)
-$39.76 M(+66.3%)
Mar 2006
-
-$9.20 M(+109.0%)
-$23.91 M(+28.5%)
Dec 2005
-$18.60 M(+27.0%)
-$4.40 M(-24.6%)
-$18.60 M(+8.0%)
Sept 2005
-
-$5.84 M(+31.2%)
-$17.23 M(+19.7%)
June 2005
-
-$4.46 M(+14.4%)
-$14.39 M(0.0%)
Mar 2005
-
-$3.90 M(+28.5%)
-$14.39 M(-1.7%)
Dec 2004
-$14.64 M(+46.6%)
-$3.03 M(+0.9%)
-$14.64 M(+26.1%)
Sept 2004
-
-$3.00 M(-32.5%)
-$11.61 M(+34.9%)
June 2004
-
-$4.46 M(+7.4%)
-$8.60 M(+427.4%)
Mar 2004
-
-$4.15 M(-264.8%)
-$1.63 M(-142.5%)
Dec 2003
-$9.98 M(-32.8%)
-
-
June 2003
-
$2.52 M(+89.7%)
$3.84 M(+189.7%)
Mar 2003
-
$1.33 M
$1.33 M
Dec 2002
-$14.86 M(+142.7%)
-
-
Dec 2001
-$6.12 M(-57.1%)
-
-
Dec 2000
-$14.27 M
-
-

FAQ

  • What is NuVasive annual earnings before interest & taxes?
  • What is the all time high annual EBIT for NuVasive?
  • What is NuVasive quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for NuVasive?
  • What is NuVasive TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for NuVasive?

What is NuVasive annual earnings before interest & taxes?

The current annual EBIT of NUVA is $69.75 M

What is the all time high annual EBIT for NuVasive?

NuVasive all-time high annual earnings before interest & taxes is $254.63 M

What is NuVasive quarterly earnings before interest & taxes?

The current quarterly EBIT of NUVA is $18.49 M

What is the all time high quarterly EBIT for NuVasive?

NuVasive all-time high quarterly earnings before interest & taxes is $60.22 M

What is NuVasive TTM earnings before interest & taxes?

The current TTM EBIT of NUVA is $60.92 M

What is the all time high TTM EBIT for NuVasive?

NuVasive all-time high TTM earnings before interest & taxes is $141.10 M